| Date Filed | Type | Description |
| 08/09/2023 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 50,000 rights
@ $0 |
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2023 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 11/08/2022 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.875, valued at
$35k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2020 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,132 shares
@ $4.87, valued at
$20.1k
Exercised 14,572 restricted stock units
@ $0 |
|
| 05/11/2020 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Sold 40,000 shares
@ $5, valued at
$200k
|
|
| 05/04/2020 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Sold 40,000 shares
@ $3.7, valued at
$148k
Sold 40,000 shares
@ $4, valued at
$160k
|
|
| 05/01/2020 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Sold 40,000 shares
@ $4.5, valued at
$180k
|
|
| 04/02/2020 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 97 shares
@ $2.19, valued at
$212.4
Exercised 329 restricted stock units
@ $0 |
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/26/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2019 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 14,572 shares
@ $7.79, valued at
$113.5k
Exercised 14,572 restricted stock units
@ $0 |
|
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2019 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,460 shares
@ $3.8, valued at
$24.5k
Exercised 14,572 restricted stock units
@ $0 |
|
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2019 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,591 shares
@ $3.72, valued at
$24.5k
Exercised 14,572 restricted stock units
@ $0 |
|
| 04/01/2019 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 263 shares
@ $6.91, valued at
$1.8k
Exercised 329 restricted stock units
@ $0 |
|
| 03/04/2019 |
4
| Schobel Alexander Mark (SVP,Chief Innov/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Granted 75,000 options to buy
@ $8.05, valued at
$603.8k
|
|
| 03/01/2019 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,721 shares
@ $8.05, valued at
$54.1k
Exercised 14,572 restricted stock units
@ $0 |
|
| 01/03/2019 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 162 shares
@ $6.3, valued at
$1k
Exercised 329 restricted stock units
@ $0 |
|
| 12/11/2018 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $7.78, valued at
$7.8k
|
|
| 12/10/2018 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $8.69, valued at
$17.4k
|
|
| 12/04/2018 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,177 shares
@ $8.59, valued at
$61.7k
Exercised 14,572 restricted stock units
@ $0 |
|
| 11/26/2018 |
4
| Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.|
Txns:
| Bought 1,000 shares
@ $10.25, valued at
$10.3k
|
|
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|